BR9611396A - Composto para tratamento de lesão cerebral traumática - Google Patents

Composto para tratamento de lesão cerebral traumática

Info

Publication number
BR9611396A
BR9611396A BR9611396A BR9611396A BR9611396A BR 9611396 A BR9611396 A BR 9611396A BR 9611396 A BR9611396 A BR 9611396A BR 9611396 A BR9611396 A BR 9611396A BR 9611396 A BR9611396 A BR 9611396A
Authority
BR
Brazil
Prior art keywords
compound
treatment
brain injury
traumatic brain
traumatic
Prior art date
Application number
BR9611396A
Other languages
English (en)
Inventor
Brian R Pike
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BR9611396A publication Critical patent/BR9611396A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9611396A 1995-11-06 1996-11-05 Composto para tratamento de lesão cerebral traumática BR9611396A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK123295 1995-11-06
PCT/DK1996/000458 WO1997017074A1 (en) 1995-11-06 1996-11-05 Treatment of traumatic brain injury

Publications (1)

Publication Number Publication Date
BR9611396A true BR9611396A (pt) 1999-07-13

Family

ID=8102484

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611396A BR9611396A (pt) 1995-11-06 1996-11-05 Composto para tratamento de lesão cerebral traumática

Country Status (18)

Country Link
EP (1) EP0866706A1 (pt)
JP (1) JPH11514654A (pt)
KR (1) KR19990067353A (pt)
AU (1) AU706594B2 (pt)
BG (1) BG63150B1 (pt)
BR (1) BR9611396A (pt)
CA (1) CA2234824A1 (pt)
CZ (1) CZ287441B6 (pt)
EA (1) EA000531B1 (pt)
HU (1) HUP9901051A2 (pt)
IS (1) IS4726A (pt)
NO (1) NO982036L (pt)
NZ (1) NZ321546A (pt)
PL (1) PL326490A1 (pt)
SK (1) SK58198A3 (pt)
TR (1) TR199800801T2 (pt)
WO (1) WO1997017074A1 (pt)
ZA (1) ZA969320B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR013096A1 (es) * 1997-07-01 2000-12-13 Lundbeck & Co As H Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
IE922270A1 (en) * 1991-07-26 1993-01-27 Akzo Nv Pyrazole derivatives
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives

Also Published As

Publication number Publication date
CZ287441B6 (en) 2000-11-15
JPH11514654A (ja) 1999-12-14
TR199800801T2 (xx) 1998-08-21
MX9803432A (es) 1998-09-30
IS4726A (is) 1998-04-27
CA2234824A1 (en) 1997-05-15
NO982036D0 (no) 1998-05-05
BG102480A (en) 1999-01-29
AU7490096A (en) 1997-05-29
SK58198A3 (en) 1998-10-07
NZ321546A (en) 2000-12-22
ZA969320B (en) 1997-05-30
EA000531B1 (ru) 1999-10-28
HUP9901051A2 (hu) 2000-03-28
KR19990067353A (ko) 1999-08-16
CZ138998A3 (cs) 1998-10-14
WO1997017074A1 (en) 1997-05-15
PL326490A1 (en) 1998-09-28
AU706594B2 (en) 1999-06-17
EA199800434A1 (ru) 1998-10-29
BG63150B1 (bg) 2001-05-31
NO982036L (no) 1998-06-25
EP0866706A1 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
AU1436595A (en) Method of treatment of traumatic brain injury
BR9507166A (pt) Conjunto de dentes para tratamento de uma superfície
BR9508886A (pt) Compostos e métodos para o tratamento de câncer
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
PT861081E (pt) Utilizacao de epinastina para o tratamento de dores
BR9602695A (pt) Composto método e composição para tratamento de distúrbios hiperproliferativos
BR9503812A (pt) Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto
BR9603841A (pt) Aparelho para o tratamento hipertérmico de tumores
HUP9904525A3 (en) Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan
DE69734513D1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
PT101165A (pt) Processo para a preparacao de inibidores duais sem sintese e sem ciclo-oxigenase
BR9707489A (pt) Composto composição farmacêutica e processo para tratar um paciente sofrendo de um distúrbio fisilógico
BR9506271A (pt) Processo para o tratamento de aves domésticas
PT96725A (pt) Processo para o tratamento de graos de cacau
BR9611396A (pt) Composto para tratamento de lesão cerebral traumática
PT983275E (pt) Novos derivados do triptolido vantajosos para o tratamento de doencas autoimunes
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
BR9606766A (pt) Utilização de compostos e processo para o tratamento e profilaxia de disturbios degenerativos cerebrais
EE200000391A (et) Triasiiniühendid kesknärvisüsteemihäirete raviks
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
BR9307043A (pt) Processo para preparação de dinitro-tolueno
GB9510162D0 (en) Compositions for the treatment of skin conditions
HUP9902167A3 (en) Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
BR9607308A (pt) Processo para preparação de monohidrato de loracarbef

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal